BASELINE SERUM PROTEIN LEVELS ASSOCIATED WITH SURVIVAL IN AXALIMOGENE FILOLISBAC (AXAL)-TREATED METASTATIC CERVICAL CANCER PATIENTS: THE GOG/NRG-0265 TRIAL

Hayes, SM; Petit, RG; Balli, D; Hong, Q; Huh, W; Brady, WE; Dizon, D; Powell, MA; Leath, CA; Landrum, LM; Tanner, E; Higgins, R; Ueda, S; McHale, M; Aghajanian, C; Monk, BJ

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017; 27 ( ): 118